Volume | 364,815 |
|
|||||
News | - | ||||||
Day High | 16.01 | Low High |
|||||
Day Low | 15.33 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
15.79 | 15.33 | 16.01 | 15.35 | 16.05 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5,893 | 364,815 | US$ 15.66 | US$ 5,714,773 | - | 11.83 - 28.80 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:54:24 | 1 | US$ 15.65 | USD |
REGENXBIO Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
682.41M | 44.43M | - | 90.24M | -263.49M | -5.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
REGENXBIO News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.67 | 16.80 | 15.29 | 16.05 | 396,360 | -0.32 | -2.04% |
1 Month | 21.17 | 21.19 | 15.18 | 17.71 | 443,605 | -5.82 | -27.49% |
3 Months | 12.26 | 28.80 | 12.05 | 19.81 | 751,863 | 3.09 | 25.20% |
6 Months | 14.57 | 28.80 | 11.83 | 18.37 | 651,314 | 0.78 | 5.35% |
1 Year | 19.40 | 28.80 | 11.83 | 18.33 | 515,358 | -4.05 | -20.88% |
3 Years | 34.51 | 46.46 | 11.83 | 24.58 | 434,845 | -19.16 | -55.52% |
5 Years | 51.33 | 55.23 | 11.83 | 30.80 | 443,815 | -35.98 | -70.10% |
REGENXBIO Description
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |